Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug‐outcome associations: The case of clindamycin and Clostridium difficile infection

• Ryan M. CarnahanUniversity of Iowa
• Jennifer L. KuntzKaiser Permanente Center for Health Research
• Shirley V. WangBrigham and Women's Hospital
• Candace C. FullerHarvard University
• Joshua J. GagneBrigham and Women's Hospital
• Charles E. LeonardUniversity of Pennsylvania
• Sean HennessyUniversity of Pennsylvania
• Tamra E. MeyerUnited States Food and Drug Administration
• Patrick ArchdeaconUnited States Food and Drug Administration
• Chih‐Ying ChenUnited States Food and Drug Administration
• Catherine A. PanozzoHarvard University
• Sengwee TohHarvard University
• Hannah KatcoffHarvard University
• Tiffany Siu WoodworthHarvard University
• Aarthi IyerHarvard University
• Sophia AxtmanHarvard University
• Elizabeth A. ChrischillesUniversity of Iowa